There are numerous non-invasive methods that can be used for the prediction of fibrosis, including the AST/ALT ratio (AAR), APRI, FIB4 and the NAFLD fibrosis score [13, 14, 16–18]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.